Status:
NOT_YET_RECRUITING
Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acne Scars
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
compare the efficacy and safety of treating atrophic post acne scars with topical insulin versus Platelet rich Plasma PRP combined with fractional ablative Co2 laser
Detailed Description
Acne vulgaris is a common cutaneous inflammatory disorder of the pilosebaceous unit, which runs a chronic course. The condition commonly manifests with papules, pustules, or nodules primarily on the f...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- patients aged equal or more than 18 years with atrophic post acne scars.
- Exclusion criteria:
- pregnancy and lactation. Hypertrophic scars. patients suffering from aggressive inflammatory acne. kidney or liver disease. active infection at site of lesion. patients use medications that reduce tissue healing during the study.
Exclusion
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06590909
Start Date
November 1 2024
End Date
July 1 2027
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.